Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Closure Medical improves delivery for Dermabond:

This article was originally published in Clinica

Executive Summary

Closure Medical has launched two delivery systems for its Dermabond topical skin adhesive that it claims substantially improves the product's ease of use. The ProPen and ProPen XL devices allow doctors to apply a high-viscosity formulation of Dermabond more precisely and control its flow better, says the Raleigh, North Carolina firm. ProPen is a single-use device with interchangeable tips, which allows for fine-line delivery of adhesive for those wound closures requiring precise application. The XL version differs in that it will deliver twice the express volume as the ProPen for closing long surgical incisions. All Dermabond products are distributed by Ethicon, a Johnson & Johnson company.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064057

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel